Ausgabe 3-4/2012
Special Issue: Metastasis Genes
Inhalt (37 Artikel)
The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis
Fanyan Meng, Guojun Wu
Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
N. P. A. Devika Gunasinghe, Alan Wells, Erik W. Thompson, Honor J. Hugo
Growth factor signaling in metastasis: current understanding and future opportunities
Frank J. Lowery, Dihua Yu
Regulation of the metastatic cell phenotype by sialylated glycans
Matthew J. Schultz, Amanda F. Swindall, Susan L. Bellis
Maspin: molecular mechanisms and therapeutic implications
Thomas M. Bodenstine, Richard E. B. Seftor, Zhila Khalkhali-Ellis, Elisabeth A. Seftor, Philip A. Pemberton, Mary J. C. Hendrix
KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis
Sung-Gook Cho, Dali Li, Kunrong Tan, Stefan K. Siwko, Mingyao Liu
Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene
Natascia Marino, Joji Nakayama, Joshua W. Collins, Patricia S. Steeg
Using MKK4’s metastasis suppressor function to identify and dissect cancer cell–microenvironment interactions during metastatic colonization
Venkatesh Krishnan, Nathan Stadick, Robert Clark, Russell Bainer, Jennifer T. Veneris, Shaheena Khan, Angela Drew, Carrie Rinker-Schaeffer
Driving transcriptional regulators in melanoma metastasis
Aaron K. Mobley, Russell R. Braeuer, Takafumi Kamiya, Einav Shoshan, Menashe Bar-Eli
Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment
Evi S. Lianidou, Athina Markou, Areti Strati
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Natalia Bednarz-Knoll, Catherine Alix-Panabières, Klaus Pantel
Non-glucose metabolism in cancer cells—is it all in the fat?
Swethajit Biswas, John Lunec, Kim Bartlett
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Céline Bourgier, Antonin Levy, Marie-Catherine Vozenin, Eric Deutsch
Ovarian cancer molecular pathology
Rémi Longuespée, C. Boyon, Annie Desmons, Denis Vinatier, Eric Leblanc, Isabelle Farré, Maxence Wisztorski, Kévin Ly, François D’Anjou, Robert Day, Isabelle Fournier, Michel Salzet
Cancer stem cells, microRNAs, and therapeutic strategies including natural products
Darshni Vira, Saroj K. Basak, Mysore S. Veena, Marilene B. Wang, Raj K. Batra, Eri S. Srivatsan
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
Francesco Crea, Lorenzo Fornaro, Guido Bocci, Lei Sun, William L. Farrar, Alfredo Falcone, Romano Danesi
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Koichi Ito, Kimberley Stannard, Elwyn Gabutero, Amanda M. Clark, Shi-Yong Neo, Selda Onturk, Helen Blanchard, Stephen J. Ralph
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
Jie Ni, Paul J. Cozzi, Wei Duan, Sarah Shigdar, Peter H. Graham, Kearsley H. John, Yong Li
Transcription factor PROX1: its role in development and cancer
Tamador Elsir, Anja Smits, Mikael S. Lindström, Monica Nistér
Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny
Kenichi Suda, Hiroshi Mizuuchi, Yoshihiko Maehara, Tetsuya Mitsudomi
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
Emmanouil Fokas, W. Gillies McKenna, Ruth J. Muschel
The role of FOXP3 in the development and metastatic spread of breast cancer
Stephen Douglass, Simi Ali, Annette P. Meeson, David Browell, John A. Kirby